Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complications of retroperitoneal lymph node dissection.

R Bihrle1, J P Donohue, R S Foster

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis.

The Urologic Clinics of North America
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Urologic oncology·2018
Same author

Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series.

International urology and nephrology·2014
Same author

[Nerve sparing retroperitoneal lymphadenectomy (RLA)].

Aktuelle Urologie·2010
Same author

Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.

BJU international·2003
Same author

Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.

The Journal of urology·2001
Same author

Germ cell tumor associated primitive neuroectodermal tumors.

The Journal of urology·2001

Retroperitoneal lymph node dissection for low-stage testis cancer has minimal complications, particularly with nerve-sparing methods. Patients needing post-chemotherapy surgery face higher risks, requiring careful monitoring.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Retroperitoneal lymph node dissection (RPLND) is a key procedure for managing testis cancer.
  • Nerve-sparing techniques have improved outcomes for early-stage disease.

Purpose of the Study:

  • To evaluate the complication rates of RPLND in low-stage testis cancer.
  • To identify patient groups at higher risk for complications following RPLND.

Main Methods:

  • Review of complications associated with RPLND.
  • Analysis of outcomes based on surgical approach (nerve-sparing vs. traditional).
  • Assessment of risk factors for complications in patients undergoing post-chemotherapy RPLND.

Main Results:

  • RPLND for low-stage testis cancer generally has minimal complications, especially with nerve-sparing techniques.

Related Experiment Videos

  • Approximately 30% of patients require post-chemotherapy RPLND due to incomplete remission.
  • These patients face a significantly higher risk of intraoperative and postoperative complications.

    • Conclusions:

    • Nerve-sparing RPLND is a safe and effective approach for low-stage testis cancer.
    • Vigilance regarding potential complications is crucial for patients undergoing post-chemotherapy RPLND.
    • Awareness and management of risks can reduce morbidity in high-risk patient cohorts.